Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$844K Sell
4,993
-761
-13% -$133K 0.02% 610
2025
Q4
$939K Buy
5,754
+1,151
+25% +$173K 0.02% 568
2025
Q3
$623K Sell
4,603
-297
-6% -$42K 0.02% 476
2025
Q2
$635K Buy
4,900
+3,059
+166% +$357K 0.02% 514
2025
Q1
$222K Buy
+1,841
New +$237K 0.02% 505

Other funds holding NUE

Callan Family Office's NUE Position: Q1 2026 in Review

Callan Family Office reduced its Nucor (NUE) stake by 13% in Q1 2026, selling an estimated $133K and leaving 4,993 shares worth $844K. The position accounts for 0.02% of the portfolio, ranked #610.

Callan Family Office first reported a position in NUE in Q1 2025 and has held it in 5 quarters since. The position peaked at $939K in Q4 2025. 1,371 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Callan Family Office held 4,993 shares of Nucor worth $844K as of Q1 2026.
  • Callan Family Office sold 761 Nucor shares in Q1 2026, an estimated $133K.
  • Nucor made up 0.02% of Callan Family Office's portfolio in Q1 2026, its #610 holding.
  • Callan Family Office first reported a position in Nucor in Q1 2025 and has held it in 5 quarters since.
  • Callan Family Office's Nucor position peaked at $939K in Q4 2025.
  • 1,371 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.